What AI says about TrialPilot

TrialPilot is a platform for decentralized clinical trials that runs the entire study from the participant’s phone—from enrollment, consent and wearable data collection to safety monitoring and results—turning a person’s signals into regulator-grade evidence. It provides researchers with a real-time command center and patients with a guided app, enabling simultaneous access to the same data with no clinic walls and supporting designs from randomized, placebo-controlled trials to observational real-world data and n-of-1 studies. The platform supports multiple participation models (home-delivered investigational drugs, clinician-prescribed therapies, or self-designed studies), with simple enrollment via shareable study links and continuous data flow across the study lifecycle.

AI named TrialPilot from June 2026 to September 2026.

Questions and answers

TrialPilot in AI’s own words

Question: What platforms support n-of-1 therapy design or personalized medicine workflows?

ChatGPTSep 5, 2026

trialpilot.app — A decentralized clinical trial platform that supports single-subject studies

ChatGPTAsk ChatGPT yourself (opens in a new tab)Google AI ModeAsk Google AI Mode yourself (opens in a new tab)

Question: Which platforms combine CTMS features with wearable data, patient apps, and remote study management?

ChatGPTAug 28, 2026

TrialPilot is another DCT-oriented platform. It supports remote participation through mobile apps, wearables, telehealth

ChatGPTAsk ChatGPT yourself (opens in a new tab)Google AI ModeAsk Google AI Mode yourself (opens in a new tab)

Competitors

AI named TrialPilot most often alongside Empatica, Veeva, and Ametris.

Sources AI cites

AI cited trialpilot.app in these answers, after empatica.com, medidata.com, and pmc.ncbi.nlm.nih.gov.

trialpilot.app 8%Other sites 92%